Otsuka Holdings Co., Ltd. (TYO:4578)

Market Cap	3.75T
Revenue (ttm)	2.39T
Net Income (ttm)	350.74B
Shares Out	528.05M
EPS (ttm)	649.83
PE Ratio	10.92
Forward PE	13.47
Dividend	120.00 (1.69%)
Ex-Dividend Date	Jun 27, 2025

Volume	1,687,100
Average Volume	1,471,955
Open	7,074.00
Previous Close	7,039.00
Day's Range	6,959.00 - 7,087.00
52-Week Range	6,465.00 - 9,669.00
Beta	0.06
RSI	51.36
Earnings Date	Jul 31, 2025

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1921
• Employees: 35,338
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4578

Financial Performance

In 2024, Otsuka Holdings's revenue was 2.33 trillion, an increase of 15.42% compared to the previous year's 2.02 trillion. Earnings were 343.12 billion, an increase of 182.13%.